Showing results (331-340 of 1,842) with videos related to
Sort By:
Pageof 185
Journal of Managed Care & Specialty Pharmacy|August 30, 2018
Health-Related Quality of Life Assessments with Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes MellitusLiana K Billings, Yehuda Handelsman, Michael Heile, et al.Journal of Managed Care & Specialty Pharmacy|August 30, 2018
Health Care Utilization and Direct Costs Among Patients Diagnosed with Cluster Headache in U.S. Health Care Claims DataCasey K Choong, Janet H Ford, Allen W Nyhuis, et al.Journal of Managed Care & Specialty Pharmacy|August 30, 2018
The Effect of Age and Comorbidities on the Association Between the Medicare STAR Oral Antihyperglycemic Adherence Metric and Glycemic ControlGregory A Nichols, Marsha A Raebel, Wendy Dyer, et al.Journal of Managed Care & Specialty Pharmacy|August 30, 2018
Novel Type 2 Diabetes Medication Access and Effect of Patient Cost SharingHenry J Henk, Janice M S Lopez, Brahim K BookhartJournal of Managed Care & Specialty Pharmacy|August 30, 2018
Evaluation of the HealthImpact Diabetes Risk Model in the Veterans Health AdministrationJonathan R Linder, Nancee V Waterbury, Bruce Alexander, et al.Journal of Managed Care & Specialty Pharmacy|August 8, 2018
Patient-Administered Biologic and Biosimilar Filgrastim May Offer More Affordable Options for Patients with Nonmyeloid Malignancies Receiving Chemotherapy in the United States: A Budget Impact Analysis from the Payer PerspectiveHolly Trautman, Erika Szabo, Elizabeth James, et al.Journal of Managed Care & Specialty Pharmacy|September 1, 2016
How Do Pharmacists Assist Medicare Beneficiaries with Limited Income? A Cross-Sectional Study of Community Pharmacies in AlabamaSalisa C Westrick, Tessa J Hastings, Stuart J McFarland, et al.Journal of Managed Care & Specialty Pharmacy|September 1, 2016
Pharmacy Benefits Management in the Veterans Health Administration Revisited: A Decade of Advancements, 2004-2014Sherrie L Aspinall, Mariscelle M Sales, Chester B Good, et al.Journal of Managed Care & Specialty Pharmacy|September 1, 2016
Budget Impact of Adding Ivabradine to Standard of Care in Patients with Chronic Systolic Heart Failure in the United StatesJeffrey S Borer, Anuraag R Kansal, Emily D Dorman, et al.Journal of Managed Care & Specialty Pharmacy|September 1, 2016
An Economic Evaluation of Tofacitinib Treatment in Rheumatoid Arthritis: Modeling the Cost of Treatment Strategies in the United StatesLindsay Claxton, Michelle Jenks, Matthew Taylor, et al.Pageof 185